
Algesia 200mg Tablet SR
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Aceclofenac (200mg)
Overview Algesia 200mg Tablet SR
PainMend 200mg Extended-Release Tablets offer effective pain and inflammation relief. This medication is indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Dosage and treatment duration should strictly adhere to your physician's instructions. Administering PainMend with food or milk minimizes potential stomach irritation. While generally well-tolerated, potential side effects may include nausea, diarrhea, abdominal discomfort, dizziness, indigestion, and elevated liver enzymes. Prolonged use necessitates regular monitoring of kidney and liver function, along with blood component levels, by your healthcare provider. Extended therapy carries a risk of serious complications, including gastrointestinal bleeding and renal impairment.
Uses of Algesia 200mg Tablet SR
Analgesia
Major Benefits of Algesia 200mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Algesia 200mg Sustained-Release Tablet should be administered with a meal.
Common Side effects of Algesia 200mg Tablet SR:
- Dizziness
- Indigestion
- Nausea
- Abdominal pain
- Increased liver enzymes
How to use Algesia 200mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the 200mg Algesia SR tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Algesia 200mg Tablet SR works:
Algesia 200mg Extended-Release tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and the associated signs of inflammation, such as redness and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Algesia 200mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Algesia 200mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against these risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Algesia 200mg sustained-release tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking an Algesia 200mg sustained-release tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when prescribing 200mg sustained-release Algesia tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of 200mg sustained-release Algesia tablets is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Algesia 200mg sustained-release tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Algesia 200mg SR tablet use. Physician consultation is recommended. Routine monitoring of liver function is advised during treatment.
What if you forget to take Algesia 200mg Tablet SR :
Should you forget to take a 200mg sustained-release Algesia tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Algesia 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Dichlorobenzene Derivative |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Actions | Nonselective COX-1 and COX-2 inhibitors (acetic acid derivatives) |
